CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma

BACKGROUND: Comparative genetic and biological studies on malignant tumor counterparts in human beings and laboratory mice may be powerful gene discovery tools for blood cancers, including neoplasms of mature B-lymphocytes and plasma cells such as Burkitt lymphoma (BL) and multiple myeloma (MM). MET...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Hematol Oncol
Main Authors: Han, Seong-Su, Tompkins, Van S, Son, Dong-Ju, Han, Sangwoo, Yun, Hwakyung, Kamberos, Natalie L, Dehoedt, Casey L, Gu, Chunyan, Holman, Carol, Tricot, Guido, Zhan, Fenghuang, Janz, Siegfried
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4383050/
https://ncbi.nlm.nih.gov/pubmed/25838973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-015-0005-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados